Free Trial

Axon Enterprise (AXON) Financials

Axon Enterprise logo
$842.16 +710.99 (+542.04%)
As of 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Annual Income Statements for Axon Enterprise

Annual Income Statements for Axon Enterprise

This table shows Axon Enterprise's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders
20 20 17 5.21 546 0.88 -1.72 -60 147 176 377
Consolidated Net Income / (Loss)
20 20 17 5.21 29 0.88 -1.72 -60 147 176 377
Net Income / (Loss) Continuing Operations
20 20 17 5.21 546 0.88 -1.72 -60 147 176 377
Total Pre-Tax Income
32 35 31 16 28 2.07 -6.29 -141 196 157 382
Total Operating Income
33 35 32 13 25 -6.39 -14 -168 93 157 59
Total Gross Profit
102 129 171 207 517 307 416 541 726 955 1,241
Total Revenue
165 198 268 344 840 531 681 863 1,187 1,561 2,083
Operating Revenue
165 198 268 344 840 531 681 863 1,187 1,561 2,083
Total Cost of Revenue
63 69 98 137 323 224 265 322 461 605 841
Operating Cost of Revenue
63 69 98 137 323 224 265 322 461 605 841
Total Operating Expenses
69 93 139 194 -25 314 430 709 633 799 1,183
Selling, General & Admin Expense
54 70 108 139 157 213 307 515 399 495 741
Research & Development Expense
15 24 31 55 77 101 123 194 234 304 442
Total Other Income / (Expense), net
-0.19 0.03 -0.35 2.74 3.26 8.46 7.86 27 103 0.21 323
Interest & Investment Income
-0.19 0.03 -0.35 2.74 3.26 8.46 7.86 1.48 4.29 42 37
Other Income / (Expense), net
- - - - - - - 25 99 -42 286
Income Tax Expense
12 15 14 11 -1.10 1.19 -4.57 -81 49 -19 4.47
Basic Earnings per Share
$0.38 $0.37 $0.33 $0.10 $0.52 $0.01 ($0.03) ($0.91) $2.07 $2.37 $4.98
Weighted Average Basic Shares Outstanding
52.95M 53.55M 52.67M 52.73M 56.39M 59.19M 61.78M 66.19M 71.09M 74.20M 75.75M
Diluted Earnings per Share
$0.37 $0.36 $0.32 $0.10 $0.50 $0.01 ($0.03) ($0.91) $2.03 $2.33 $4.80
Weighted Average Diluted Shares Outstanding
54.50M 54.64M 53.54M 53.90M 57.92M 60.02M 61.78M 66.19M 72.53M 75.46M 78.56M
Weighted Average Basic & Diluted Shares Outstanding
52.40M 53.90M 52.40M 52.10M 58.83M 59.53M 63.78M 70.93M 72.86M 75.30M 76.62M

Quarterly Income Statements for Axon Enterprise

This table shows Axon Enterprise's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders
29 45 12 61 57 133 41 67 136 88 36
Consolidated Net Income / (Loss)
29 45 12 61 57 133 41 67 136 88 36
Net Income / (Loss) Continuing Operations
29 45 12 61 57 133 41 67 136 88 36
Total Pre-Tax Income
34 42 -12 72 56 166 51 80 86 108 -39
Total Operating Income
22 17 40 57 43 16 34 24 -15 -8.79 -1.04
Total Gross Profit
203 204 232 257 263 259 306 331 347 366 404
Total Revenue
333 343 375 413 430 460 503 544 573 604 669
Operating Revenue
333 343 375 413 430 460 503 544 573 604 669
Total Cost of Revenue
130 139 142 157 167 201 197 214 227 238 265
Operating Cost of Revenue
130 139 142 157 167 201 197 214 227 238 265
Total Operating Expenses
181 187 192 199 220 242 272 307 362 375 405
Selling, General & Admin Expense
112 117 120 122 136 151 171 192 227 224 242
Research & Development Expense
69 71 72 77 84 91 101 114 135 151 163
Total Other Income / (Expense), net
12 25 -52 14 13 149 18 55 100 117 -38
Interest Expense
- - - - - 1.76 1.87 - - 7.82 29
Interest & Investment Income
-87 9.67 9.66 10 12 12 12 11 5.46 11 23
Other Income / (Expense), net
- 16 -62 3.85 0.67 139 7.93 45 95 114 -32
Income Tax Expense
5.48 -3.26 -25 10 -1.36 33 10 13 -50 20 -75
Basic Earnings per Share
$0.41 $0.62 $0.17 $0.82 $0.76 $1.77 $0.55 $0.89 $1.78 $1.14 $0.46
Weighted Average Basic Shares Outstanding
71.09M 72.64M 74.22M 74.83M 74.20M 75.36M 75.51M 75.70M 75.75M 76.89M 78.00M
Diluted Earnings per Share
$0.39 $0.61 $0.16 $0.81 $0.75 $1.73 $0.53 $0.86 $1.68 $1.08 $0.44
Weighted Average Diluted Shares Outstanding
72.53M 73.88M 75.78M 75.95M 75.46M 77.13M 77.55M 78.08M 78.56M 81.48M 82.06M
Weighted Average Basic & Diluted Shares Outstanding
72.86M 73.89M 74.76M 74.93M 75.30M 75.47M 75.57M 76.25M 76.62M 77.85M 78.50M

Annual Cash Flow Statements for Axon Enterprise

This table details how cash moves in and out of Axon Enterprise's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents
6.10 11 -16 34 273 -179 -17 201 -0.89 245 -134
Net Cash From Operating Activities
35 46 21 18 64 66 38 124 235 189 408
Net Cash From Continuing Operating Activities
35 46 21 18 64 66 38 124 235 189 408
Net Income / (Loss) Continuing Operations
20 20 17 5.21 29 0.88 -1.72 -60 147 176 377
Consolidated Net Income / (Loss)
20 20 17 5.21 29 0.88 -1.72 -60 147 176 377
Depreciation Expense
4.32 3.29 3.66 8.04 11 11 12 19 23 19 48
Non-Cash Adjustments To Reconcile Net Income
-1.97 0.38 9.10 17 25 86 142 285 24 191 141
Changes in Operating Assets and Liabilities, net
12 21 -10 -12 -1.42 -33 -117 -125 41 -197 -158
Net Cash From Investing Activities
-25 -36 -3.05 19 -9.86 -241 -357 253 -831 12 -491
Net Cash From Continuing Investing Activities
-25 -36 -3.05 19 -9.86 -241 -357 253 -831 12 -491
Purchase of Property, Plant & Equipment
-2.51 -6.00 -4.96 -10 -11 -16 -73 -50 -56 -60 -79
Acquisitions
-0.18 -12 -7.00 -12 -5.55 -0.40 -0.24 -23 -2.10 -21 -622
Purchase of Investments
-33 -62 -56 -20 -4.33 -354 -664 -408 -845 -564 -793
Sale and/or Maturity of Investments
11 44 65 61 11 130 380 733 72 657 1,003
Other Investing Activities, net
- - - - 0.00 - - - -0.02 -0.54 0.05
Net Cash From Financing Activities
-4.84 0.60 -35 -3.82 219 -3.94 299 -174 598 41 -45
Net Cash From Continuing Financing Activities
-4.84 0.60 -35 -3.82 219 -3.94 299 -174 598 41 -45
Repayment of Debt
-0.04 -0.08 - - - - - - 0.00 0.00 -1.84
Issuance of Debt
- - - - - - 0.00 0.00 674 0.00 0.00
Issuance of Common Equity
- - 0.00 0.00 234 0.00 0.00 0.00 124 0.00 0.00
Other Financing Activities, net
18 8.24 -0.81 -3.82 -15 -3.94 299 -174 -200 41 -44
Effect of Exchange Rate Changes
0.09 0.12 0.91 - - 0.33 1.98 -1.98 -3.38 2.07 -6.21
Cash Interest Paid
- - - - - - - - 0.00 3.51 3.45
Cash Income Taxes Paid
- - - - - - - - 11 64 68

Quarterly Cash Flow Statements for Axon Enterprise

This table details how cash moves in and out of Axon Enterprise's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Change in Cash & Equivalents
206 -90 211 -68 193 -195 163 129 -231 638 -477
Net Cash From Operating Activities
131 -56 43 63 140 -16 83 91 250 26 -92
Net Cash From Continuing Operating Activities
131 -56 43 63 140 -16 83 91 250 26 -92
Net Income / (Loss) Continuing Operations
29 45 12 61 57 133 41 68 135 88 36
Consolidated Net Income / (Loss)
29 45 12 61 57 133 41 68 135 88 36
Depreciation Expense
4.95 6.69 7.48 -1.33 6.47 7.36 13 6.18 18 19 17
Non-Cash Adjustments To Reconcile Net Income
31 22 98 32 40 -60 73 76 54 38 184
Changes in Operating Assets and Liabilities, net
66 -127 -72 -35 37 -96 -41 -65 43 -120 -329
Net Cash From Investing Activities
-529 -73 154 -122 53 -174 82 43 -442 -702 -387
Net Cash From Continuing Investing Activities
-529 -73 154 -122 53 -174 82 43 -442 -702 -387
Purchase of Property, Plant & Equipment
-12 -8.51 -13 -14 -24 -16 -11 -26 -25 -25 -23
Acquisitions
0.19 -0.13 -21 0.12 - -238 -0.03 - -384 0.00 -3.81
Purchase of Investments
-574 -145 -112 -188 -119 -251 -240 -124 -178 -1,079 -715
Sale and/or Maturity of Investments
57 81 300 80 196 330 334 194 145 402 355
Other Investing Activities, net
- - - - -0.03 0.03 - - 0.02 0.00 0.08
Net Cash From Financing Activities
601 38 14 -7.12 -3.82 -2.71 -2.19 -7.71 -33 1,313 -4.37
Net Cash From Continuing Financing Activities
601 38 14 -7.12 -3.82 -2.71 -2.19 -7.71 -33 1,313 -4.37
Repayment of Debt
- - - - - 0.00 - - - -432 -0.53
Other Financing Activities, net
-197 38 14 -102 91 -2.71 -2.19 -7.71 -31 -5.04 -3.84
Effect of Exchange Rate Changes
3.40 0.78 0.03 -2.01 3.27 -1.98 -0.11 - - 1.19 5.31
Cash Income Taxes Paid
- - - - - 1.41 - - - 0.05 50

Annual Balance Sheets for Axon Enterprise

This table presents Axon Enterprise's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets
185 230 278 169 720 846 1,381 1,688 2,852 3,409 4,475
Total Current Assets
135 161 177 114 558 609 982 1,109 1,805 2,394 2,297
Cash & Equivalents
48 60 41 - 349 172 155 356 354 599 455
Short-Term Investments
33 50 48 - 0.00 179 407 87 621 722 532
Note & Lease Receivable
31 28 39 85 131 147 229 321 358 413 548
Inventories, net
18 16 35 - 34 39 90 109 202 270 265
Prepaid Expenses
4.44 8.17 14 24 30 35 37 57 73 103 130
Other Current Assets
- - - 5.51 - 38 64 180 197 287 368
Plant, Property, & Equipment, net
18 22 24 0.00 38 44 105 138 170 201 247
Total Noncurrent Assets
33 47 77 55 123 192 294 440 877 815 1,930
Long-Term Investments
9.30 8.53 0.23 - 0.00 45 102 31 156 232 333
Noncurrent Note & Lease Receivables
- 1.23 18 24 40 32 22 11 5.21 2.59 3.46
Goodwill
2.21 9.60 10 - 25 25 25 44 45 58 757
Intangible Assets
3.12 7.59 15 - 16 13 9.45 15 12 20 175
Noncurrent Deferred & Refundable Income Taxes
16 14 20 11 19 28 46 127 157 228 304
Other Noncurrent Operating Assets
2.52 5.97 14 21 23 50 88 128 205 275 357
Total Liabilities & Shareholders' Equity
185 230 278 296 720 846 1,381 1,688 2,852 3,409 4,475
Total Liabilities
56 73 127 153 252 302 405 640 1,583 1,793 2,147
Total Current Liabilities
32 38 78 97 166 196 256 419 603 762 1,678
Short-Term Debt
0.04 0.00 1.69 - - - - - - 0.00 680
Accounts Payable
7.68 7.33 11 - 15 26 24 32 60 66 72
Accrued Expenses
9.25 8.64 18 26 41 45 60 104 156 194 279
Customer Deposits
0.99 1.23 2.15 - - - 2.96 10 20 22 21
Current Deferred Revenue
14 21 45 - 107 118 164 266 360 470 613
Other Current Liabilities
- 0.09 0.08 71 2.74 6.83 5.43 6.54 6.36 9.79 13
Total Noncurrent Liabilities
24 35 49 56 86 107 148 222 981 1,032 469
Long-Term Debt
0.03 - - - - - - - 674 677 0.00
Noncurrent Deferred Revenue
22 30 40 56 - 88 111 186 248 271 361
Noncurrent Deferred & Payable Income Tax Liabilities
1.47 1.32 1.90 - 2.85 4.19 5.15 4.61 11 18 25
Noncurrent Employee Benefit Liabilities
1.12 2.20 3.36 - 3.24 3.94 4.73 5.68 6.29 11 16
Other Noncurrent Operating Liabilities
0.00 1.03 3.92 - 80 11 27 26 42 54 67
Commitments & Contingencies
0.00 0.00 0.00 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
129 157 151 142 467 543 976 1,048 1,268 1,616 2,328
Total Preferred & Common Equity
129 157 151 142 467 543 976 1,048 1,268 1,616 2,328
Preferred Stock
0.00 0.00 0.00 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
129 157 151 142 467 543 976 1,048 1,268 1,616 2,328
Common Stock
163 178 188 - 453 528 962 1,095 1,175 1,347 1,690
Retained Earnings
81 101 118 142 171 172 170 110 257 435 812
Treasury Stock
-115 -122 -156 - -156 -156 -156 -156 -156 -156 -156
Accumulated Other Comprehensive Income / (Loss)
0.06 0.08 0.90 - -1.51 -1.10 0.14 -1.32 -7.18 -11 -18

Quarterly Balance Sheets for Axon Enterprise

This table presents Axon Enterprise's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Total Assets
2,852 3,008 3,077 3,254 3,409 3,616 3,742 4,006 4,475 6,083 6,215
Total Current Assets
1,805 2,053 2,113 2,258 2,394 2,202 2,206 2,434 2,297 3,777 3,828
Cash & Equivalents
354 263 474 406 599 404 566 695 455 1,093 615
Short-Term Investments
621 830 660 785 722 660 510 463 532 1,274 1,615
Note & Lease Receivable
358 380 372 443 413 477 386 513 548 600 628
Inventories, net
202 220 250 260 270 271 278 272 265 280 308
Prepaid Expenses
73 142 102 104 103 124 122 118 130 156 198
Other Current Assets
197 217 255 261 287 266 343 373 368 374 463
Plant, Property, & Equipment, net
170 173 179 187 201 209 215 236 247 260 271
Total Noncurrent Assets
877 783 786 809 815 1,205 1,321 1,336 1,930 2,047 2,116
Long-Term Investments
156 31 15 0.00 232 295 363 388 333 414 404
Noncurrent Note & Lease Receivables
5.21 4.47 5.28 4.38 2.59 2.40 3.04 2.90 3.46 3.32 1.63
Goodwill
45 45 58 57 58 308 308 308 757 756 762
Intangible Assets
12 11 22 20 20 89 86 82 175 169 163
Noncurrent Deferred & Refundable Income Taxes
157 171 199 214 228 209 227 244 304 336 357
Other Noncurrent Operating Assets
205 223 253 273 275 301 335 311 357 369 428
Total Liabilities & Shareholders' Equity
2,852 3,008 3,077 3,254 3,409 3,616 3,742 4,006 4,475 6,083 6,215
Total Liabilities
1,583 1,605 1,632 1,733 1,793 1,798 1,814 1,906 2,147 3,527 3,483
Total Current Liabilities
603 616 625 718 762 757 766 823 998 1,337 1,297
Short-Term Debt
- - - - - - - - - 279 279
Accounts Payable
60 66 73 90 66 82 104 76 72 98 118
Accrued Expenses
156 121 118 147 194 127 142 210 279 267 266
Customer Deposits
20 14 15 16 22 22 23 22 21 22 19
Current Deferred Revenue
360 408 412 455 470 516 486 505 613 661 603
Other Current Liabilities
6.36 7.51 7.36 9.49 9.79 9.60 12 11 13 11 11
Total Noncurrent Liabilities
981 989 1,007 1,015 1,032 1,041 1,047 1,083 1,149 2,191 2,186
Long-Term Debt
674 675 676 676 677 678 679 679 680 1,728 1,729
Noncurrent Deferred Revenue
248 250 265 270 271 294 291 305 361 349 329
Noncurrent Deferred & Payable Income Tax Liabilities
11 16 21 21 18 19 19 20 25 29 32
Noncurrent Employee Benefit Liabilities
6.29 7.98 8.77 9.15 11 15 14 16 16 19 21
Other Noncurrent Operating Liabilities
42 40 37 38 54 36 44 62 67 67 76
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,268 1,403 1,445 1,521 1,616 1,818 1,929 2,100 2,328 2,556 2,732
Total Preferred & Common Equity
1,268 1,403 1,445 1,521 1,616 1,818 1,929 2,100 2,328 2,556 2,732
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00
Total Common Equity
1,268 1,403 1,445 1,521 1,616 1,818 1,929 2,100 2,328 2,556 2,732
Common Stock
1,175 1,262 1,293 1,316 1,347 1,421 1,494 1,588 1,690 1,830 1,965
Retained Earnings
257 302 315 374 435 564 605 677 812 900 936
Treasury Stock
-156 -156 -156 -156 -156 -156 -156 -156 -156 -156 -156
Accumulated Other Comprehensive Income / (Loss)
-7.18 -5.32 -6.73 -13 -11 -12 -14 -9.12 -18 -18 -13

Annual Metrics And Ratios for Axon Enterprise

This table displays calculated financial ratios and metrics derived from Axon Enterprise's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics
- - - - - - - - - - -
Revenue Growth
19.37% 20.28% 35.55% 28.17% 144.37% -36.81% 28.28% 26.78% 37.50% 31.47% 33.44%
EBITDA Growth
13.22% 6.61% -8.70% -42.72% 68.33% -84.97% -68.66% -7,222.57% 280.80% -37.57% 192.96%
EBIT Growth
16.31% 8.71% -9.86% -59.11% 90.75% -125.74% -121.30% -909.60% 234.36% -40.11% 200.05%
NOPAT Growth
10.17% -0.60% -12.18% -75.40% 499.99% -110.55% -263.57% -1,088.15% 159.15% 152.18% -67.04%
Net Income Growth
9.18% 0.08% -13.22% -69.90% 460.88% -96.98% -295.46% -3,381.32% 344.81% 19.64% 114.49%
EPS Growth
8.82% -2.70% -11.11% -68.75% 400.00% -98.00% -400.00% -2,933.33% 323.08% 14.78% 106.01%
Operating Cash Flow Growth
9.27% 31.08% -54.49% -12.60% 245.81% 2.81% -41.41% 223.52% 89.05% -19.59% 115.74%
Free Cash Flow Firm Growth
15.87% -24.29% -135.52% 828.21% -247.41% 57.84% -444.33% -69.46% 115.11% -212.03% -1,678.79%
Invested Capital Growth
-14.03% -0.10% 63.51% -74.77% 638.11% 24.90% 111.87% 57.13% 5.08% 43.81% 128.06%
Revenue Q/Q Growth
4.31% 4.89% 10.75% 3.80% 110.07% -53.31% 28.33% 19.12% 10.81% 6.38% 7.26%
EBITDA Q/Q Growth
-0.15% -0.66% 2.01% -5.36% -13.70% -74.10% 107.52% -6.00% 217.94% -13.87% 10.35%
EBIT Q/Q Growth
-0.24% -1.16% 2.92% -11.94% -18.54% -164.04% 58.76% -5.60% 339.77% -15.99% 12.75%
NOPAT Q/Q Growth
-0.94% -0.24% 7.34% -61.09% 8.66% -130.20% 58.76% -24.28% 90.21% 18.06% -40.04%
Net Income Q/Q Growth
-1.44% 0.10% 7.70% -61.77% 16.58% -94.25% 95.68% -190.28% 40.66% 18.74% 27.20%
EPS Q/Q Growth
0.00% -2.70% 10.34% -61.54% 11.11% -95.65% 95.45% -139.47% 32.68% 18.27% 24.68%
Operating Cash Flow Q/Q Growth
10.80% 7.74% -44.51% 376.72% 12.14% 28.51% -22.99% -14.66% 100.87% 4.95% 36.93%
Free Cash Flow Firm Q/Q Growth
31.53% 5.15% -135.79% 193.54% -611.21% -113.40% -39.32% -14.87% 165.97% 39.70% -140.64%
Invested Capital Q/Q Growth
-12.18% -14.19% 52.15% -85.19% -17.16% -11.49% 16.54% 13.84% -3.71% -3.38% 36.97%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
61.72% 65.01% 63.57% 60.24% 61.56% 57.88% 61.14% 62.65% 61.16% 61.22% 59.61%
EBITDA Margin
22.96% 20.35% 13.71% 6.13% 4.22% 1.00% 0.25% -13.78% 18.12% 8.60% 18.89%
Operating Margin
19.76% 17.86% 11.87% 3.79% 2.96% -1.20% -2.08% -19.47% 7.83% 10.05% 2.81%
EBIT Margin
19.76% 17.86% 11.87% 3.79% 2.96% -1.20% -2.08% -16.55% 16.17% 7.37% 16.56%
Profit (Net Income) Margin
12.11% 10.07% 6.45% 1.51% 3.48% 0.17% -0.25% -6.95% 12.38% 11.26% 18.10%
Tax Burden Percent
61.64% 56.37% 54.92% 33.04% 103.92% 42.61% 27.40% 42.45% 74.87% 111.92% 98.83%
Interest Burden Percent
99.40% 100.07% 98.89% 121.02% 113.14% -32.37% 44.46% 98.96% 102.24% 136.64% 110.61%
Effective Tax Rate
38.36% 43.63% 45.08% 66.96% -3.92% 57.39% 0.00% 0.00% 25.13% -11.92% 1.17%
Return on Invested Capital (ROIC)
47.83% 51.45% 34.30% 10.86% 38.58% -2.06% -4.31% -29.35% 13.85% 27.96% 4.76%
ROIC Less NNEP Spread (ROIC-NNEP)
47.98% 51.43% 34.49% 10.01% 37.15% -3.02% -5.86% -38.79% 2.06% 27.93% -37.41%
Return on Net Nonoperating Assets (RNNOA)
-31.05% -37.51% -23.07% -7.31% -28.99% 2.23% 4.09% 23.42% -1.17% -15.77% 14.36%
Return on Equity (ROE)
16.78% 13.93% 11.24% 3.55% 9.58% 0.17% -0.23% -5.93% 12.69% 12.19% 19.12%
Cash Return on Invested Capital (CROIC)
62.91% 51.54% -13.90% 130.26% -113.70% -24.20% -76.06% -73.78% 8.89% -7.98% -73.31%
Operating Return on Assets (OROA)
19.48% 17.02% 12.54% 5.82% 5.59% -0.82% -1.27% -9.31% 8.46% 3.67% 8.75%
Return on Assets (ROA)
11.94% 9.60% 6.81% 2.33% 6.57% 0.11% -0.15% -3.91% 6.47% 5.62% 9.56%
Return on Common Equity (ROCE)
16.78% 13.93% 11.24% 3.55% 9.58% 0.17% -0.23% -5.93% 12.69% 12.19% 19.12%
Return on Equity Simple (ROE_SIMPLE)
15.43% 12.70% 11.46% 3.66% 6.25% 0.16% -0.18% -5.73% 11.58% 10.88% 16.20%
Net Operating Profit after Tax (NOPAT)
20 20 17 4.30 26 -2.72 -9.91 -118 70 176 58
NOPAT Margin
12.18% 10.07% 6.52% 1.25% 3.07% -0.51% -1.45% -13.63% 5.86% 11.25% 2.78%
Net Nonoperating Expense Percent (NNEP)
-0.16% 0.01% -0.19% 0.85% 1.43% 0.97% 1.54% 9.44% 11.79% 0.03% 42.17%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - 3.58% 7.66% 1.92%
Cost of Revenue to Revenue
38.28% 34.99% 36.57% 39.76% 38.44% 42.12% 38.87% 37.35% 38.84% 38.78% 40.39%
SG&A Expenses to Revenue
32.92% 35.22% 40.29% 40.34% 18.67% 40.12% 45.12% 59.65% 33.64% 31.71% 35.59%
R&D to Revenue
9.05% 11.93% 11.41% 16.11% 9.15% 18.97% 18.09% 22.47% 19.70% 19.46% 21.20%
Operating Expenses to Revenue
41.97% 47.15% 51.70% 56.45% -2.96% 59.09% 63.21% 82.12% 53.33% 51.17% 56.80%
Earnings before Interest and Taxes (EBIT)
33 35 32 13 25 -6.39 -14 -143 192 115 345
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
38 40 37 21 35 5.33 1.67 -119 215 134 393
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
10.77 5.91 8.40 9.86 5.47 8.00 7.98 10.26 9.31 11.65 18.60
Price to Tangible Book Value (P/TBV)
11.23 6.63 10.12 9.86 6.00 8.60 8.27 10.87 9.75 12.24 31.03
Price to Revenue (P/Rev)
8.45 4.69 4.72 4.08 3.04 8.19 11.43 12.45 9.95 12.06 20.79
Price to Earnings (P/E)
69.82 46.53 73.27 269.29 4.68 4,930.28 0.00 0.00 80.37 107.08 114.85
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
1.43% 2.15% 1.36% 0.37% 21.37% 0.02% 0.00% 0.00% 1.24% 0.93% 0.87%
Enterprise Value to Invested Capital (EV/IC)
33.57 20.91 18.64 87.81 18.73 26.85 22.84 20.97 22.04 24.23 25.26
Enterprise Value to Revenue (EV/Rev)
7.90 4.09 4.40 4.08 2.63 7.44 10.46 11.90 9.56 11.50 20.49
Enterprise Value to EBITDA (EV/EBITDA)
34.42 20.09 32.08 66.57 62.26 741.78 4,264.92 0.00 52.78 133.67 108.47
Enterprise Value to EBIT (EV/EBIT)
40.00 22.90 37.04 107.67 88.87 0.00 0.00 0.00 59.14 156.13 123.70
Enterprise Value to NOPAT (EV/NOPAT)
64.89 40.62 67.44 325.91 85.52 0.00 0.00 0.00 163.07 102.24 737.46
Enterprise Value to Operating Cash Flow (EV/OCF)
36.70 17.42 55.82 75.91 34.56 60.18 185.09 82.54 48.23 94.83 104.49
Enterprise Value to Free Cash Flow (EV/FCFF)
49.33 40.55 0.00 27.17 0.00 0.00 0.00 0.00 253.99 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.53 0.42 0.29
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.53 0.42 0.29
Financial Leverage
-0.65 -0.73 -0.67 -0.73 -0.78 -0.74 -0.70 -0.60 -0.57 -0.56 -0.38
Leverage Ratio
1.41 1.45 1.65 1.53 1.46 1.55 1.47 1.52 1.96 2.17 2.00
Compound Leverage Factor
1.40 1.45 1.63 1.85 1.65 -0.50 0.65 1.50 2.00 2.97 2.21
Debt to Total Capital
0.05% 0.00% 1.11% 0.00% 0.00% 0.00% 0.00% 0.00% 34.70% 29.53% 22.62%
Short-Term Debt to Total Capital
0.03% 0.00% 1.11% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.02% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 34.70% 29.53% 22.62%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
99.95% 100.00% 98.89% 100.00% 100.00% 100.00% 100.00% 100.00% 65.30% 70.47% 77.38%
Debt to EBITDA
0.00 0.00 0.05 0.00 0.00 0.00 0.00 0.00 3.13 5.04 1.73
Net Debt to EBITDA
-2.39 0.00 -2.38 0.00 0.00 0.00 0.00 0.00 -2.12 -6.52 -1.62
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.13 5.04 1.73
Debt to NOPAT
0.00 0.00 0.10 0.00 0.00 0.00 0.00 0.00 9.68 3.86 11.76
Net Debt to NOPAT
-4.51 0.00 -5.01 0.00 0.00 0.00 0.00 0.00 -6.56 -4.99 -11.04
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.68 3.86 11.76
Altman Z-Score
17.57 10.26 8.34 9.06 8.35 10.11 12.80 10.89 5.75 7.62 13.42
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.21 4.23 2.27 1.17 3.36 3.12 3.83 2.65 3.00 3.14 2.30
Quick Ratio
3.50 3.60 1.65 0.87 2.98 2.54 3.09 1.83 2.21 2.28 1.54
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
26 20 -7.09 52 -76 -32 -175 -296 45 -50 -891
Operating Cash Flow to CapEx
1,420.12% 778.89% 430.01% 177.69% 573.44% 412.03% 53.05% 249.77% 421.78% 317.37% 518.26%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.99 0.95 1.06 1.54 1.89 0.68 0.61 0.56 0.52 0.50 0.53
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
4.28 4.06 3.88 0.00 0.00 6.16 4.11 3.25 2.96 2.56 3.14
Fixed Asset Turnover
9.00 10.05 11.70 0.00 0.00 13.00 9.12 7.08 7.70 8.43 9.30
Accounts Payable Turnover
9.06 9.22 10.86 0.00 0.00 10.90 10.58 11.44 10.01 9.62 12.21
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
85.29 89.84 94.13 0.00 0.00 59.27 88.81 112.42 123.17 142.42 116.11
Days Payable Outstanding (DPO)
40.29 39.57 33.61 0.00 0.00 33.50 34.49 31.90 36.47 37.92 29.90
Cash Conversion Cycle (CCC)
45.00 50.26 60.52 0.00 0.00 25.77 54.33 80.52 86.70 104.50 86.21
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
39 39 63 16 118 147 312 490 515 741 1,689
Invested Capital Turnover
3.93 5.11 5.26 8.68 12.56 4.01 2.97 2.15 2.36 2.49 1.71
Increase / (Decrease) in Invested Capital
-6.32 -0.04 25 -47 102 29 165 178 25 226 948
Enterprise Value (EV)
1,300 809 1,180 1,402 2,208 3,952 7,122 10,275 11,352 17,947 42,665
Market Capitalization
1,391 927 1,267 1,402 2,557 4,349 7,787 10,749 11,808 18,822 43,303
Book Value per Share
$2.46 $2.93 $2.89 $2.69 $8.00 $9.16 $15.36 $15.30 $17.82 $21.56 $30.52
Tangible Book Value per Share
$2.36 $2.61 $2.40 $2.69 $7.30 $8.52 $14.82 $14.44 $17.02 $20.53 $18.30
Total Capital
129 157 153 142 467 543 976 1,048 1,942 2,293 3,008
Total Debt
0.07 0.00 1.69 0.00 0.00 0.00 0.00 0.00 674 677 680
Total Long-Term Debt
0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 674 677 680
Net Debt
-90 -118 -88 0.00 -349 -396 -664 -474 -457 -875 -639
Capital Expenditures (CapEx)
2.50 5.96 4.92 10 11 16 73 50 56 60 79
Debt-free, Cash-free Net Working Capital (DFCFNWC)
22 13 12 17 43 63 164 248 228 312 314
Debt-free Net Working Capital (DFNWC)
103 123 101 17 392 414 726 691 1,203 1,632 1,300
Net Working Capital (NWC)
103 123 99 17 392 414 726 691 1,203 1,632 1,300
Net Nonoperating Expense (NNE)
0.12 -0.01 0.19 -0.90 -3.39 -3.61 -8.18 -58 -77 -0.24 -319
Net Nonoperating Obligations (NNO)
-90 -118 -88 -126 -349 -396 -664 -558 -753 -875 -639
Total Depreciation and Amortization (D&A)
5.27 4.94 4.92 8.04 11 12 16 24 23 19 48
Debt-free, Cash-free Net Working Capital to Revenue
13.11% 6.82% 4.40% 4.92% 5.08% 11.89% 24.03% 28.72% 19.20% 19.96% 15.06%
Debt-free Net Working Capital to Revenue
62.43% 62.29% 37.61% 4.92% 46.68% 77.97% 106.55% 80.03% 101.30% 104.58% 62.42%
Net Working Capital to Revenue
62.40% 62.29% 36.98% 4.92% 46.68% 77.97% 106.55% 80.03% 101.30% 104.58% 62.42%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.38 $0.37 $0.33 $0.10 $0.52 $0.01 ($0.03) ($0.91) $2.07 $2.35 $4.98
Adjusted Weighted Average Basic Shares Outstanding
52.95M 53.55M 52.67M 52.73M 56.39M 59.19M 61.78M 66.19M 71.09M 74.20M 75.75M
Adjusted Diluted Earnings per Share
$0.37 $0.36 $0.32 $0.10 $0.50 $0.01 ($0.03) ($0.91) $2.03 $2.31 $4.80
Adjusted Weighted Average Diluted Shares Outstanding
54.50M 54.64M 53.54M 53.90M 57.92M 60.02M 61.78M 66.19M 72.53M 75.46M 78.56M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
53.09M 53.69M 52.33M 53.03M 58.83M 59.53M 63.78M 70.93M 72.86M 75.30M 76.62M
Normalized Net Operating Profit after Tax (NOPAT)
20 20 17 9.12 17 -4.48 -9.91 -118 70 110 58
Normalized NOPAT Margin
12.18% 10.07% 6.52% 2.65% 2.07% -0.84% -1.45% -13.63% 5.86% 7.04% 2.78%
Pre Tax Income Margin
19.64% 17.87% 11.74% 4.58% 3.35% 0.39% -0.92% -16.37% 16.53% 10.06% 18.32%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
112.67% 37.91% 195.10% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Axon Enterprise

This table displays calculated financial ratios and metrics derived from Axon Enterprise's official financial filings.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
53.21% 33.78% 31.16% 32.57% 28.93% 34.31% 34.57% 31.70% 33.42% 31.26% 32.85%
EBITDA Growth
228.45% 54.81% -163.62% 57.96% 82.69% 354.82% 389.84% 24.73% 96.86% -23.22% -131.29%
EBIT Growth
182.25% 87.38% -201.69% 90.83% 94.21% 382.17% 287.43% 11.95% 85.43% -32.09% -180.23%
NOPAT Growth
198.79% 37.53% 76.75% 162.82% 132.96% -26.88% -5.93% -58.67% -153.53% -153.96% -102.67%
Net Income Growth
314.44% -17.74% -75.63% 405.39% 96.49% 195.13% 228.48% 9.32% 138.94% -34.02% -12.91%
EPS Growth
454.55% -19.74% -77.46% 376.47% 92.31% 183.61% 231.25% 6.17% 124.00% -37.57% -16.98%
Operating Cash Flow Growth
914.08% -228.11% 120.15% 53.77% 6.80% 71.70% 94.02% 45.20% 78.64% 261.84% -210.80%
Free Cash Flow Firm Growth
96.85% -8.17% -25.75% -113.18% -2,834.38% -210.88% -102.52% -144.35% -433.92% -39.77% -132.79%
Invested Capital Growth
5.08% 34.40% 44.65% 43.33% 43.81% 73.09% 58.37% 60.87% 128.06% 56.76% 80.32%
Revenue Q/Q Growth
6.93% 2.05% 9.20% 10.32% 3.99% 6.62% 9.41% 7.97% 5.35% 5.27% 10.75%
EBITDA Q/Q Growth
-28.31% 29.86% -149.38% 439.39% -17.09% 230.16% -68.54% 46.06% 30.86% 27.82% -113.03%
EBIT Q/Q Growth
-30.67% 42.93% -167.58% 381.42% -29.44% 262.88% -73.73% 68.08% 16.87% 31.74% -131.67%
NOPAT Q/Q Growth
0.24% -5.48% 57.45% 74.15% -11.15% -70.21% 102.57% -23.48% -215.06% 69.42% 89.84%
Net Income Q/Q Growth
138.78% 54.72% -72.49% 393.63% -7.17% 132.61% -69.38% 64.29% 102.90% -35.31% -58.95%
EPS Q/Q Growth
129.41% 56.41% -73.77% 406.25% -7.41% 127.63% -69.36% 62.26% 95.35% -35.71% -59.26%
Operating Cash Flow Q/Q Growth
220.58% -142.96% 175.73% 47.44% 122.66% -111.38% 619.28% 10.34% 173.94% -89.69% -455.52%
Free Cash Flow Firm Q/Q Growth
92.76% -2,409.42% -32.82% 8.43% 0.35% -162.36% 13.48% -10.48% -117.74% 32.87% -43.90%
Invested Capital Q/Q Growth
-3.71% 27.51% 12.30% 3.95% -3.38% 54.25% 2.75% 5.59% 36.97% 5.49% 18.19%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
60.94% 59.50% 61.96% 62.10% 61.10% 56.44% 60.25% 60.77% 60.49% 60.59% 60.39%
EBITDA Margin
8.16% 10.43% -4.72% 14.51% 11.56% 35.31% 10.16% 13.74% 17.06% 20.72% -2.44%
Operating Margin
6.68% 4.84% 10.75% 13.89% 9.90% 3.53% 6.52% 4.42% -2.56% -1.46% -0.16%
EBIT Margin
6.68% 9.39% -5.81% 14.83% 10.06% 33.72% 8.10% 12.60% 13.98% 17.50% -5.00%
Profit (Net Income) Margin
8.69% 13.16% 3.32% 14.83% 13.24% 28.91% 8.09% 12.31% 23.72% 14.58% 5.40%
Tax Burden Percent
84.08% 107.77% -102.57% 85.47% 102.44% 80.39% 80.64% 84.24% 158.83% 81.17% -92.89%
Interest Burden Percent
154.76% 130.00% 55.62% 117.07% 128.51% 106.68% 123.97% 116.01% 106.81% 102.64% 116.24%
Effective Tax Rate
15.92% -7.77% 0.00% 14.53% -2.44% 19.61% 19.36% 15.76% -58.83% 18.83% 0.00%
Return on Invested Capital (ROIC)
13.26% 11.63% 16.47% 26.77% 25.22% 5.33% 9.99% 7.24% -6.98% -1.80% -0.16%
ROIC Less NNEP Spread (ROIC-NNEP)
11.70% 7.69% 18.74% 25.09% 23.59% -11.50% 8.05% 1.47% -28.03% -14.87% -5.47%
Return on Net Nonoperating Assets (RNNOA)
-6.62% -4.21% -9.88% -13.23% -13.32% 5.10% -3.50% -0.66% 10.76% 4.95% 1.63%
Return on Equity (ROE)
6.64% 7.43% 6.59% 13.55% 11.90% 10.42% 6.49% 6.58% 3.78% 3.15% 1.47%
Cash Return on Invested Capital (CROIC)
8.89% -15.95% -15.79% -12.76% -7.98% -37.32% -32.04% -37.02% -73.31% -41.88% -57.43%
Operating Return on Assets (OROA)
3.49% 5.02% -3.17% 8.26% 5.02% 17.11% 4.30% 6.74% 7.39% 8.03% -2.40%
Return on Assets (ROA)
4.54% 7.03% 1.81% 8.27% 6.60% 14.68% 4.30% 6.59% 12.53% 6.69% 2.60%
Return on Common Equity (ROCE)
6.64% 7.43% 6.59% 13.55% 11.90% 10.42% 6.49% 6.58% 3.78% 3.15% 1.47%
Return on Equity Simple (ROE_SIMPLE)
0.00% 9.79% 6.84% 9.73% 0.00% 14.43% 15.07% 14.12% 0.00% 12.98% 0.00%
Net Operating Profit after Tax (NOPAT)
19 18 28 49 44 13 27 20 -23 -7.14 -0.73
NOPAT Margin
5.61% 5.22% 7.52% 11.88% 10.15% 2.84% 5.26% 3.73% -4.07% -1.18% -0.11%
Net Nonoperating Expense Percent (NNEP)
1.56% 3.94% -2.27% 1.69% 1.63% 16.83% 1.95% 5.77% 21.05% 13.07% 5.31%
Return On Investment Capital (ROIC_SIMPLE)
0.96% - - - 1.90% - - - -0.78% -0.16% -0.02%
Cost of Revenue to Revenue
39.06% 40.50% 38.04% 37.90% 38.90% 43.56% 39.75% 39.23% 39.51% 39.41% 39.61%
SG&A Expenses to Revenue
33.65% 33.98% 32.01% 29.61% 31.65% 33.14% 33.61% 35.31% 39.58% 37.03% 36.23%
R&D to Revenue
20.62% 20.68% 19.20% 18.60% 19.54% 19.77% 20.12% 21.03% 23.47% 25.02% 24.32%
Operating Expenses to Revenue
54.27% 54.66% 51.22% 48.21% 51.19% 52.91% 53.73% 56.34% 63.05% 62.05% 60.55%
Earnings before Interest and Taxes (EBIT)
22 32 -22 61 43 155 41 69 80 106 -33
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
27 36 -18 60 50 163 51 75 98 125 -16
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
9.31 11.68 9.84 9.53 11.65 12.54 11.12 13.87 18.60 14.99 22.08
Price to Tangible Book Value (P/TBV)
9.75 12.17 10.41 10.04 12.24 16.05 13.96 17.03 31.03 23.49 33.37
Price to Revenue (P/Rev)
9.95 12.83 10.41 9.88 12.06 13.56 11.84 15.00 20.79 17.21 25.22
Price to Earnings (P/E)
80.37 119.23 143.80 97.94 107.08 86.91 73.75 98.23 114.85 115.55 184.87
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
1.24% 0.84% 0.70% 1.02% 0.93% 1.15% 1.36% 1.02% 0.87% 0.87% 0.54%
Enterprise Value to Invested Capital (EV/IC)
22.04 24.26 18.64 18.24 24.23 19.46 17.71 22.91 25.26 21.07 28.35
Enterprise Value to Revenue (EV/Rev)
9.56 12.48 10.06 9.53 11.50 13.16 11.42 14.55 20.49 16.87 24.96
Enterprise Value to EBITDA (EV/EBITDA)
52.78 140.48 105.69 89.71 133.67 85.35 63.05 79.25 108.47 105.61 207.90
Enterprise Value to EBIT (EV/EBIT)
59.14 171.94 123.24 102.21 156.13 93.70 69.25 92.34 123.70 127.28 271.54
Enterprise Value to NOPAT (EV/NOPAT)
163.07 207.61 106.41 94.05 102.24 152.20 165.19 292.76 737.46 1,101.81 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
48.23 117.96 86.79 77.54 94.83 96.30 76.65 94.74 104.49 83.43 216.63
Enterprise Value to Free Cash Flow (EV/FCFF)
253.99 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.53 0.48 0.47 0.44 0.42 0.37 0.35 0.32 0.29 0.79 0.73
Long-Term Debt to Equity
0.53 0.48 0.47 0.44 0.42 0.37 0.35 0.32 0.29 0.68 0.63
Financial Leverage
-0.57 -0.55 -0.53 -0.53 -0.56 -0.44 -0.44 -0.45 -0.38 -0.33 -0.30
Leverage Ratio
1.96 1.89 1.90 1.91 2.17 2.06 2.02 2.01 2.00 2.22 2.14
Compound Leverage Factor
3.03 2.46 1.06 2.24 2.79 2.19 2.51 2.33 2.14 2.28 2.48
Debt to Total Capital
34.70% 32.47% 31.86% 30.78% 29.53% 27.16% 26.03% 24.45% 22.62% 43.98% 42.36%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 6.11% 5.89%
Long-Term Debt to Total Capital
34.70% 32.47% 31.86% 30.78% 29.53% 27.16% 26.03% 24.45% 22.62% 37.87% 36.47%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
65.30% 67.53% 68.14% 69.22% 70.47% 72.84% 73.97% 75.55% 77.38% 56.02% 57.64%
Debt to EBITDA
3.13 5.95 5.20 4.34 5.04 2.62 2.07 1.91 1.73 5.64 6.99
Net Debt to EBITDA
-2.12 -3.97 -3.64 -3.30 -6.52 -2.63 -2.32 -2.43 -1.62 -2.18 -2.18
Long-Term Debt to EBITDA
3.13 5.95 5.20 4.34 5.04 2.62 2.07 1.91 1.73 4.86 6.02
Debt to NOPAT
9.68 8.79 5.23 4.55 3.86 4.67 5.42 7.04 11.76 58.89 -956.52
Net Debt to NOPAT
-6.56 -5.86 -3.67 -3.46 -4.99 -4.69 -6.08 -8.98 -11.04 -22.71 298.45
Long-Term Debt to NOPAT
9.68 8.79 5.23 4.55 3.86 4.67 5.42 7.04 11.76 50.70 -823.48
Altman Z-Score
5.55 7.30 6.37 6.26 7.55 8.91 8.30 10.43 13.23 7.63 11.46
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.00 3.33 3.38 3.15 3.14 2.91 2.88 2.96 2.30 2.83 2.95
Quick Ratio
2.21 2.39 2.41 2.28 2.28 2.03 1.91 2.03 1.54 2.22 2.20
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-6.20 -150 -199 -183 -182 -467 -404 -446 -972 -652 -939
Operating Cash Flow to CapEx
1,131.91% -661.61% 324.78% 450.06% 583.22% -98.63% 731.25% 344.97% 1,008.69% 103.75% -399.53%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -83.41 -32.72
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.30 -3.20
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.12 -4.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.52 0.53 0.55 0.56 0.50 0.51 0.53 0.53 0.53 0.46 0.48
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
2.96 2.92 2.63 2.62 2.56 2.72 2.76 2.95 3.14 3.19 3.23
Fixed Asset Turnover
7.70 7.92 8.10 8.36 8.43 8.81 9.18 9.18 9.30 9.49 9.83
Accounts Payable Turnover
10.01 8.66 7.94 8.11 9.62 9.05 8.22 9.47 12.21 9.77 8.51
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
123.17 125.09 139.03 139.05 142.42 133.95 132.31 123.85 116.11 114.55 113.16
Days Payable Outstanding (DPO)
36.47 42.14 46.00 45.02 37.92 40.35 44.41 38.53 29.90 37.37 42.89
Cash Conversion Cycle (CCC)
86.70 82.96 93.04 94.04 104.50 93.61 87.90 85.32 86.21 77.18 70.27
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
515 657 737 767 741 1,137 1,168 1,233 1,689 1,782 2,106
Invested Capital Turnover
2.36 2.23 2.19 2.25 2.49 1.87 1.90 1.94 1.71 1.53 1.46
Increase / (Decrease) in Invested Capital
25 168 228 232 226 480 430 467 948 645 938
Enterprise Value (EV)
11,352 15,933 13,743 13,985 17,947 22,116 20,678 28,249 42,665 37,548 59,699
Market Capitalization
11,808 16,383 14,217 14,499 18,822 22,797 21,439 29,116 43,303 38,322 60,326
Book Value per Share
$17.82 $19.26 $19.56 $20.35 $21.56 $24.13 $25.56 $27.79 $30.52 $33.36 $35.10
Tangible Book Value per Share
$17.02 $18.48 $18.48 $19.31 $20.53 $18.85 $20.35 $22.62 $18.30 $21.29 $23.22
Total Capital
1,942 2,078 2,121 2,197 2,293 2,496 2,608 2,779 3,008 4,563 4,740
Total Debt
674 675 676 676 677 678 679 679 680 2,007 2,008
Total Long-Term Debt
674 675 676 676 677 678 679 679 680 1,728 1,729
Net Debt
-457 -450 -474 -514 -875 -681 -761 -867 -639 -774 -626
Capital Expenditures (CapEx)
12 8.51 13 14 24 16 11 26 25 25 23
Debt-free, Cash-free Net Working Capital (DFCFNWC)
228 343 353 349 312 380 363 452 314 352 580
Debt-free Net Working Capital (DFNWC)
1,203 1,437 1,487 1,540 1,632 1,444 1,440 1,611 1,300 2,719 2,811
Net Working Capital (NWC)
1,203 1,437 1,487 1,540 1,632 1,444 1,440 1,611 1,300 2,440 2,531
Net Nonoperating Expense (NNE)
-10 -27 16 -12 -13 -120 -14 -47 -159 -95 -37
Net Nonoperating Obligations (NNO)
-753 -746 -708 -755 -875 -681 -761 -867 -639 -774 -626
Total Depreciation and Amortization (D&A)
4.95 3.56 4.11 -1.33 6.47 7.36 10 6.18 18 19 17
Debt-free, Cash-free Net Working Capital to Revenue
19.20% 26.89% 25.88% 23.82% 19.96% 22.63% 20.06% 23.29% 15.06% 15.80% 24.24%
Debt-free Net Working Capital to Revenue
101.30% 112.54% 108.92% 104.97% 104.58% 85.91% 79.51% 82.95% 62.42% 122.13% 117.52%
Net Working Capital to Revenue
101.30% 112.54% 108.92% 104.97% 104.58% 85.91% 79.51% 82.95% 62.42% 109.60% 105.84%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.41 $0.62 $0.17 $0.79 $0.76 $1.77 $0.54 $0.89 $1.78 $1.14 $0.46
Adjusted Weighted Average Basic Shares Outstanding
71.09M 72.64M 74.22M 74.83M 74.20M 75.36M 75.51M 75.70M 75.75M 76.89M 78.00M
Adjusted Diluted Earnings per Share
$0.39 $0.61 $0.16 $0.78 $0.75 $1.73 $0.53 $0.86 $1.68 $1.08 $0.44
Adjusted Weighted Average Diluted Shares Outstanding
72.53M 73.88M 75.78M 75.95M 75.46M 77.13M 77.55M 78.08M 78.56M 81.48M 82.06M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
72.86M 73.89M 74.76M 74.93M 75.30M 75.47M 75.57M 76.25M 76.62M 77.85M 78.50M
Normalized Net Operating Profit after Tax (NOPAT)
19 12 28 49 30 13 27 20 -10 -7.14 -0.73
Normalized NOPAT Margin
5.61% 3.39% 7.52% 11.88% 6.93% 2.84% 5.26% 3.73% -1.79% -1.18% -0.11%
Pre Tax Income Margin
10.33% 12.21% -3.23% 17.36% 12.93% 35.97% 10.04% 14.62% 14.93% 17.96% -5.82%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 13.50 -1.17
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.91 -0.03
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 10.32 -1.97
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -4.09 -0.83
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Key Financial Trends

Over the last four years through Q1 2025, Axon Enterprise (NASDAQ:AXON) has demonstrated significant growth and operational changes across key financial metrics. Here are the main takeaways from analyzing the income statements, balance sheets, and cash flow statements:

  • Revenue Growth: Operating revenue increased steadily from $311.8 million in Q3 2022 to $603.6 million in Q1 2025, nearly doubling in roughly two and a half years, indicating strong sales momentum.
  • Gross Profit Improvement: Gross profit grew from $193.3 million in Q3 2022 to $365.7 million in Q1 2025, showing that Axon has managed to scale revenues with good cost controls relative to sales.
  • Increasing R&D Investment: Research & development expenses increased from $59.1 million in Q3 2022 to $151.0 million in Q1 2025, indicating continued investment in innovation and product development.
  • Strong Net Income Recovery: Despite some volatility, net income rose from $12.1 million in Q3 2022 to $87.98 million in Q1 2025. The company overcame operating losses in some quarters through healthy other income and overall business growth.
  • Cash & Equivalents Growth: Cash and equivalents expanded from $147.7 million in Q3 2022 to $1.09 billion in Q1 2025, reflecting strong liquidity and cash generation capability.
  • Debt Profile Increases: Total long-term debt increased from approximately $675 million in Q1 2023 to $1.73 billion in Q1 2025, showing a significant rise in leverage which could impact financial flexibility.
  • Significant Investments Activity: In Q1 2025 alone, Axon had large purchase of investments (~$1.08 billion), which may be strategic but represents a substantial cash outflow and requires monitoring for returns.
  • Operating Cash Flow Variability: Operating cash flow has fluctuated quarter to quarter, including a notable negative operating cash flow in Q1 2024, reflecting working capital changes and non-cash adjustments.
  • Operating Income Pressures: Operating income was negative in multiple recent quarters (e.g., -$8.79 million in Q1 2025 and -$14.7 million in Q4 2024), indicating operational challenges despite revenue growth.
  • Increasing Operating Expenses: Total operating expenses have risen significantly, mainly driven by selling, general & administrative expenses and R&D, which have pressured operating margins.

Summary: Axon Enterprise has shown strong top-line growth and expanding profitability in the last four years, supported by continuous investment in R&D and increasing product demand. Cash reserves are robust, but rising debt and recent operational margin pressures present challenges. Investors should watch for how Axon manages operating expenses and leverage while capitalizing on growth opportunities.

08/08/25 04:29 PMAI Generated. May Contain Errors.

Frequently Asked Questions About Axon Enterprise's Financials

When does Axon Enterprise's financial year end?

According to the most recent income statement we have on file, Axon Enterprise's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Axon Enterprise's net income changed over the last 10 years?

Axon Enterprise's net income appears to be on an upward trend, with a most recent value of $377.03 million in 2024, rising from $19.92 million in 2014. The previous period was $175.78 million in 2023.

What is Axon Enterprise's operating income?
Axon Enterprise's total operating income in 2024 was $58.54 million, based on the following breakdown:
  • Total Gross Profit: $1.24 billion
  • Total Operating Expenses: $1.18 billion
How has Axon Enterprise's revenue changed over the last 10 years?

Over the last 10 years, Axon Enterprise's total revenue changed from $164.53 million in 2014 to $2.08 billion in 2024, a change of 1,165.8%.

How much debt does Axon Enterprise have?

Axon Enterprise's total liabilities were at $2.15 billion at the end of 2024, a 19.7% increase from 2023, and a 3,715.9% increase since 2014.

How much cash does Axon Enterprise have?

In the past 10 years, Axon Enterprise's cash and equivalents has ranged from $0.00 in 2017 to $598.55 million in 2023, and is currently $454.84 million as of their latest financial filing in 2024.

How has Axon Enterprise's book value per share changed over the last 10 years?

Over the last 10 years, Axon Enterprise's book value per share changed from 2.46 in 2014 to 30.52 in 2024, a change of 1,141.7%.



This page (LON:AXON) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners